The state order of the most important and expensive drugs remained almost without new products
The need to save budget funds may affect the expansion of the list of drugs purchased under federal programs. Since...
The need to save budget funds may affect the expansion of the list of drugs purchased under federal programs. Since...
Many global pharmaceutical companies, having abandoned direct advertising of their drugs in Russia after the outbreak of hostilities in Ukraine,...
The Ministry of Industry and Trade of the Russian Federation announced that there are no risks of a shortage of...
The drug manufacturer R-Pharm, founded by businessman Alexei Repik, has left the capital of Albiogen, which specializes in the distribution...
Pharmaceutical companies in the Russian Federation have increased the demand for personnel, follows from a report prepared by the recruiting...
The Ministry of Health, the Ministry of Finance and the Federal Antimonopoly Service are discussing the possibility of a risk-sharing...
The State Duma explained to foreign pharmaceutical companies under what conditions the “Patent on the Shelf” mechanism will operate, allowing...
740 permits to conduct clinical trials in Russia were issued by the Ministry of Health last year. This is 18.5%...
The All-Russian Union of Patients (VSP) is asking the government of the Russian Federation to temporarily cancel the requirement to...
In 2022, the largest pharmaceutical companies, including Pfizer, BioNTech, Moderna, Gilead, AstraZeneca and Merck, earned about $100 billion from COVID-19...
Today, December 12, American biotechnology company Amgen announced on the purchase of the Irish pharmaceutical company Horizon Therapeutics. The deal...
The policy of Indian pharmaceutical companies and the low cost of their generics allow them to claim the status of...
The Ministry of Industry and Trade of the Russian Federation did not receive a notification about the termination of supplies...
European pharmaceutical companies have warned that they may stop the production of a number of low-cost generics due to rising...
Workers in IT, communications, the media, as well as organizations that ensure the stability of the national payment system and...